Abstract
Purpose
Altered fractionation radiotherapy with concomitant boost (AFRT-CB) may be considered an alternative treatment for patients not appropriate for chemoradiation (CRT). As functional outcomes following AFRT-CB have been minimally reported, this exploratory paper describes the outcomes of patients managed with AFRT-CB or CRT at 6 months post-treatment.
Methods
Using a cross-sectional analysis design, functional outcomes of 14 AFRT-CB and 17 CRT patients with T1–T3 oropharyngeal cancers were explored at 6 months post-treatment. Clinical and instrumental swallow assessments, weight and nutritional status, and the functional impact of treatment were examined.
Results
Inferior outcomes were observed for the CRT patients on the RBHOMS (p = 0.03) which was reflected in diet and fluid restrictions with 18% of the CRT group requiring modified fluids and diets. Although a trend (p = 0.07) was noted for increased lingual deficits and aspiration risk for fluids in the CRT group, no other significant differences were observed. Both groups experienced an average of 10 kg weight loss and reported reduced general and swallowing-related function.
Conclusions
These preliminary data suggest functional outcomes following AFRT-CB and CRT were largely comparable at 6 months post-treatment. Treatment intensification in any form may contribute to impaired function which requires multidimensional intervention. Larger cohort investigations with systematic methodology are needed to further examine these initial findings.
Similar content being viewed by others
References
Adelstein D, Li Y, Adams G, Wagner H Jr, Kish J, Ensley J et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21(1):92–98
Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL et al (2000) A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48(1):7–16
Jackson S, Weir L, Hay J, Tsang V, Durham J (1997) A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol 43(1):39–46
Caudell JJ, Schaner PE, Meredith RF, Locher JL, Nabell LM, Carroll WR et al (2009) Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 73(2):410–415
Logemann JA, Rademaker AW, Pauloski BR, Lazarus CL, Mittal BB, Brockstein B et al (2006) Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck 28(1):64–73
Yu K, Chua M, Vlantis A, Kam M, Lee W, Tsang R et al (2005) Swallowing function after altered fractionation radiotherapy for head and neck carcinoma. Journal Hong Kong College of Radiologists 8(4):207–213
Ang KK, Peters LJ, Weber RS, Maor MH, Morrison WH, Wendt CD et al (1990) Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 19(6):1339–1345
Denham JW, Peters LJ, Johansen J, Poulsen M, Lamb DS, Hindley A et al (1999) Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol 52(2):157–164
Dörr W, Hendry JH (2001) Consequential late effects in normal tissues. Radiother Oncol 61(3):223–231
Pignon J, Maître A, Maillard E, Bourhis J (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4–14
Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26(21):3582–3589
Graner D, Foote R, Kasperbauer J, Stoeckel R, Okuno S, Olsen K et al (2003) Swallow function in patients before and after intra-arterial chemoradiation. Laryngoscope 113(3):573–579
Kotz T, Costello R, Li Y, Posner M (2004) Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck 26(4):365–372
Lazarus C, Logemann JA, Pauloski BR, Rademaker AW, Helenowski IB, Vonesh EF et al (2007) Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer. Head Neck 29(7):632–637
Goguen L, Posner M, Norris C, Tishler R, Wirth L, Annino D et al (2006) Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Otolaryngol Head Neck Surg 134(6):916–922
Logemann JA, Pauloski BR, Rademaker AW, Lazarus CL, Gaziano J, Stachowiak L et al (2008) Swallowing disorders in the first year after radiation and chemoradiation. Head Neck 30(2):148–158
List MA, Siston A, Haraf D, Schumm P, Kies M, Stenson K et al (1999) Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol 17(3):1020–1028
Oates J, Clark J, Read J, Reeves N, Gao K, Jackson M et al (2007) Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 133(6):533
Lee H, Havrila C, Bravo V, Shantz K, Diaz K, Larner J et al (2008) Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma. Support Care Cancer 16(3):285–289
Hammerlid E, Wirblad B, Sandin C, Mercke C, Edstrom S, Kaasa S et al (1998) Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head Neck 20(6):540–548
van den Berg M, Rasmussen-Conrad E, Gwasara G, Krabbe P, Naber A, Merkx M (2006) A prospective study on weight loss and energy intake in patients with head and neck cancer, during diagnosis, treatment and revalidation. Clin Nutr 25(5):765–772
Schueller P, Schaefer U, Micke O, Willich N (1999) Results of simultaneous radiochemotherapy vs concomitant boost radiation in patients with inoperable cancer of the head and neck. Eur J Cancer 35(4):S174
Cartmill B, Cornwell P, Ward EC, Davidson W, Porceddu SV (2011) A prospective investigation of swallowing, nutrition, and patient-rated functional impact following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer. Dysphagia (in press)
Dietitians Association of Australia and The Speech Pathology Association of Australia Limited (2007) Texture-modified foods and thickened fluids as used for individuals with dysphagia: Australian standardized labels and definitions. Nutr Diet 64(Suppl. 2):S53–S76
Ward EC, Conroy A-L (1999) Validity, reliability, and responsivity of the royal brisbane hospital outcome measure for swallowing. Asia Pacific Journal of Speech Language and Hearing 4:109–129
Huckabee M-L (n.d.) New Zealand Index for Multidisciplinary Evaluation of Swallowing (NZIMES). Retrieved March 25, 2007 from http://www.cmds,canterbury.ac.nz/documetns/nzimesa4.pdf
Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL (1996) A penetration-aspiration scale. Dysphagia 11(2):93–98
Ottery F (2000) Patient-generated subjective global assessment. In: McCallum P, Polisena C (eds) The clinical guide to oncology nutrition. The American Dietetic Association, Chicago, pp 11–23
Chen AY, Frankowshi R, Bishop-Leone J, Hebert T, Leyk S, Lewin J et al (2001) The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 127(7):870–876
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579
Abdel-Wahab MMDP, Abitbol AMD, Lewin AMD, Troner MMD, Hamilton KP, Markoe AMDS (2005) Quality-of-life assessment after hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma. Am J Clin Oncol 28(4):359–366
Ackerstaff AH, Balm AJM, Rasch CRN, de Boer JP, Wiggenraad R, Rietveld DHF et al (2009) First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial. Head Neck 31(1):77–84
Pauloski BR, Rademaker AW, Logemann JA, Newman L, MacCracken E, Gaziano J et al (2006) Relationship between swallow motility disorders on videofluorography and oral intake in patients treated for head and neck cancer with radiotherapy with or without chemotherapy. Head Neck 28(12):1069
Trotti A (2000) Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 47(1):1–12
van der Molen L, van Rossum M, Burkhead L, Smeele L, Hilgers F (2009) Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review. Eur Arch Otorhinolaryngol 266(6):889–900
Mittal BB, Pauloski BR, Haraf DJ, Pelzer HJ, Argiris A, Vokes EE et al (2003) Swallowing dysfunction: preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys 57(5):1219–1230
Ringash J, Lockwood G, O'Sullivan B, Warde P, Bayley A, Cummings B et al (2008) Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial. Radiother Oncol 87(2):181–187
Gillespie M, Brodsky M, Day T, Lee F, Martin-Harris B (2004) Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope 114(8):1362–1367
Pauloski BR, Rademaker AW, Logemann JA, Lazarus CL, Newman L, Hamner A et al (2002) Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck 24(6):555–565
Logemann J, Pauloski B, Rademaker A, Colangelo L, Kahrilas P, Smith C (2000) Temporal and biomechanical characteristics of oropharyngeal swallow in younger and older men. J Speech Lang Hear Res 43(5):1264
Acknowledgements
The authors would like to acknowledge the Queensland Cancer Council; Cancer Collaborative Group, Princess Alexandra Hospital; Radiation Oncology Department, Princess Alexandra Hospital; Speech Pathology Australia; and Allied Health Research Scheme, Princess Alexandra Hospital who have awarded funding for this research.
Conflict of interest
No source of funding was involved in study design, data collection, data analysis or interpretation, manuscript writing or the decision to submit the manuscript for publication. The author has had full control of the primary data which are available for review if requested.
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper aims to inform research by providing further evidence for functional outcomes following non-surgical treatment for head and neck cancer.
Rights and permissions
About this article
Cite this article
Cartmill, B., Cornwell, P., Ward, E. et al. Swallowing, nutrition and patient-rated functional outcomes at 6 months following two non-surgical treatments for T1–T3 oropharyngeal cancer. Support Care Cancer 20, 2073–2081 (2012). https://doi.org/10.1007/s00520-011-1316-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-011-1316-4